Spruce Biosciences Inc. (SPRB) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Spruce Biosciences Inc.

    NASDAQ: SPRB · Real-Time Price · USD
    8.60
    0.00 (0.00%)
    At close: Oct 03, 2025, 3:31 PM
    8.67
    0.81%
    After-hours: Oct 03, 2025, 05:09 PM EDT

    Spruce Biosciences Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -53.04M -47.92M -46.18M -42.29M
    Depreciation & Amortization
    		 46K 70K 74K 68K
    Stock-Based Compensation
    		 5.35M 4.62M 3.63M 3.96M
    Other Working Capital
    		 -6.53M 8.45M 2.53M 806K
    Other Non-Cash Items
    		 249K -404K -340K 313K
    Deferred Income Tax
    		 n/a n/a n/a 121K
    Change in Working Capital
    		 -8.57M 10.36M 1.13M 1.96M
    Operating Cash Flow
    		 -55.96M -33.27M -41.68M -35.88M
    Capital Expenditures
    		 n/a -7K -8K -93K
    Cash Acquisitions
    		 n/a n/a -23.7M n/a
    Purchase of Investments
    		 n/a -11.88M -36.8M -79.08M
    Sales Maturities Of Investments
    		 n/a 67.67M 60.5M 121K
    Other Investing Acitivies
    		 n/a n/a 23.7M -121K
    Investing Cash Flow
    		 n/a 55.78M 23.69M -79.17M
    Debt Repayment
    		 -1.62M -1.62M n/a 220K
    Common Stock Repurchased
    		 66K n/a -40K 134K
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a -2.85M -201K 423K
    Financial Cash Flow
    		 -1.62M 49.14M -241K 643K
    Net Cash Flow
    		 -57.59M 71.64M -18.23M -114.4M
    Free Cash Flow
    		 -55.96M -33.28M -41.69M -35.97M

    Add to Watchlist